A Step Towards Hope and Healing
PAPUA NEW GUINEA’s ANGAU General Hospital in Lae marked a significant milestone last month, securing a license from the National Institute of Standards and Industrial Technology (Nisit) for the transportation of two cobalt-60 radioactive sources. These crucial components are earmarked for utilization in the hospital’s cutting-edge radiotherapy facility, poised to revolutionize cancer treatment in the region.
Under the vigilant oversight of the Radiation Safety and Control division, a pivotal arm of
Nisit, stringent safety protocols governed every aspect of the radioactive material’s transportation journey. From ensuring the provision of adequate transport shielding for the cobalt-60 source to meticulously vetting and certifying the competence of the designated driver, every precaution was taken to safeguard against potential hazards. The engagement of security personnel to oversee material movement, coupled with the conspicuous display of radiation warning signs on the transport, underscored the gravity of the undertaking.
Reuben Harokaveh, acting executive manager for the Radiation Safety and Control division,
elucidated the critical nature of the license, emphasizing the potentially dire consequences
of mishandling cobalt-60—a category one radioactive source. Harokaveh’s stark warning
underscored the imperative of meticulous management, as improper handling could result
in irrevocable harm to individuals and the environment alike.
ANGAU Hospital’s successful navigation of the rigorous safety requirements not only ensured compliance but also signaled a steadfast commitment to prioritizing the safety and
well-being of all stakeholders. With regulatory approval secured, the stage is set for the seamless integration of the cobalt-60 source into the hospital’s radiotherapy arsenal—a development poised to redefine cancer care in Papua New Guinea.
In acknowledging the significance of the license, Harokaveh reiterated its instrumental
role in facilitating the smooth importation of the cobalt-60 source, emphasizing ANGAU
Hospital’s obligation to uphold the stipulated license conditions. The hospital’s unwavering
dedication to adhering to regulatory standards underscores its pivotal role as a beacon of healthcare excellence in the region. As Papua New Guinea’s newly established regulatory
authority for ionizing radiation, PNG Nisit stands at the forefront of ensuring compliance
with all regulatory frameworks. Collaborating closely with ANGAU’s leadership team,
including Chief Executive Officer Dr. Kipas Binga and Radiotherapy Manager Becky Pais, PNG Nisit remains steadfast in its commitment to facilitating the operationalization of the cancer facility by the first quarter of 2024 — an embodiment of the government’s steadfast
commitment to advancing healthcare accessibility and quality across the nation.
A beacon of hope is emerging in the form of the ANGAU General Hospital in Lae. Recently,
this esteemed institution achieved a significant milestone that has the potential to redefine
healthcare in the region: the acquisition of a license from the National Institute of Standards
and Industrial Technology (Nisit) for the transportation of two cobalt-60 radioactive sources. These sources, destined for use in the hospital’s state-of-the-art radiotherapy facility, represent a quantum leap forward in the battle against cancer—a disease that has long
plagued communities and claimed countless lives across Papua New Guinea.
At the core of this groundbreaking development lies a commitment to excellence and
safety that transcends mere bureaucratic formalities. The meticulous efforts of the Radiation
Safety and Control division, operating under Nisit, ensured that every aspect of the
transportation process adhered to the strictest safety standards. From the selection of appropriate transport shielding for the cobalt-60 source to the rigorous vetting of the designated driver, no detail was overlooked in safeguarding against potential hazards. The engagement of security personnel to oversee material movement and the conspicuous display of radiation warning signs on the transport underscored the gravity of the undertaking—a testament to the unwavering dedication to protecting both people and the environment.
Reuben Harokaveh, acting executive manager for the Radiation Safety and Control division,
articulated the gravity of the situation, emphasizing the inherent risks associated with
cobalt-60—a category one radioactive source. Harokaveh’s sobering assessment served as a
stark reminder of the profound responsibility borne by all stakeholders involved in the transportation process. Indeed, the potential consequences of mishandling cobalt-60 extend
far beyond the confines of the hospital walls, posing a threat to the broader community
and environment if not managed with utmost care and diligence.
Against this backdrop of heightened awareness and responsibility, ANGAU Hospital emerged as a paragon of excellence, successfully navigating the rigorous safety requirements and securing regulatory approval for the transportation of the cobalt-60 source. This monumental achievement not only underscores the hospital’s unwavering commitment to advancing cancer care but also heralds a new era of hope and healing for patients across Papua New Guinea.
As the cobalt-60 sources make their way to ANGAU Hospital, they carry with them the
promise of improved treatment options and better outcomes for cancer patients—a population that has long been underserved and marginalized in the region. With access to cutting-edge radiotherapy technology, patients will no longer be forced to travel long distances or endure prolonged waiting times for treatment, leveling the playing field and ensuring equitable access to care for all.
In acknowledging the significance of the license, Harokaveh emphasized its instrumental
role in facilitating the seamless importation of the cobalt-60 sources, while also underscoring
ANGAU Hospital’s obligation to uphold the stipulated license conditions. The hospital’s steadfast dedication to adhering to regulatory standards serves as a shining example
of accountability and integrity—an example that other healthcare institutions would do
well to emulate. As Papua New Guinea’s newly established regulatory authority for ionizing
radiation, PNG Nisit remains committed to ensuring compliance with all regulatory
frameworks and supporting the safe and effective implementation of radiotherapy services
across the country. Collaborating closely with ANGAU’s leadership team, including Chief
Executive Officer Dr. Kipas Binga and Radiotherapy Manager Becky Pais, PNG Nisit stands
poised to usher in a new era of cancer care that prioritizes excellence, safety, and compassion above all else.
In closing, the acquisition of a license for the transportation of cobalt-60 sources represents
more than just a bureaucratic formality; it symbolizes a collective commitment to advancing
healthcare accessibility and quality in Papua New Guinea. As these radioactive
sources journey towards ANGAU Hospital, they carry with them the promise of hope and
healing—a promise that, with the dedication and determination of all involved, is destined to be fulfilled.
Comments